Relative effectiveness and the European pharmaceutical market.
Bengt
B
Jönsson
D057186:Comparative Effectiveness Research / Q000458:organization & administration*; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004345:Drug Industry / Q000458:organization & administration*; D005062:European Union / Q000458:organization & administration*; D006291:Health Policy; D006801:Humans; D007349:Insurance, Health, Reimbursement; D013222:State Medicine / Q000458:organization & administration*; D013673:Technology Assessment, Biomedical / Q000458:organization & administration
Clin Ther. 2008 May;30(5):960-3
18555942
Eur J Health Econ. 2011 Jun;12(3):263-71
20803050
Nat Rev Drug Discov. 2010 Apr;9(4):277-91
20186141
Health Policy. 2010 Aug;96(3):179-90
20226559
Stat Med. 2010 Aug 30;29(19):1963-76
20564311
Clin Ther. 2010 Jun;32(6):1091-2
20637963
Ann Oncol. 2007 Apr;18 Suppl 3:iii1-iii77
17494969
N Engl J Med. 2010 Oct 14;363(16):1495-7
20942664
Eur J Health Econ. 2010 Dec;11(6):521-3
21046185